[Mental disorders in blepharospasm].

Area of Science:

• Neurology
• Psychiatry
• Clinical Psychology

Context:

• Blepharospasm (BS) is a focal dystonia often accompanied by significant psychological distress.
• Assessing mental health comorbidities is crucial for comprehensive BS management.
• Botulinum therapy (BT) is a primary treatment for BS motor symptoms.

Purpose:

• To investigate the prevalence and nature of mental disorders in blepharospasm patients before and after botulinum therapy (BT).
• To compare the mental health status of BS patients with a healthy control group.
• To determine the impact of BT on anxiety and depressive symptoms in BS.

Summary:

• Patients with blepharospasm exhibited higher rates of anxiety (56%) and depression (52%) compared to controls.
• Mental health issues in BS patients often predated the motor symptoms and were not solely linked to BS severity.
• While BT showed a slight reduction in anxiety and depression, these conditions persisted, indicating a need for psychiatric intervention beyond motor symptom management.

Impact:

• Highlights the significant comorbidity of anxiety and depressive disorders in blepharospasm patients.
• Suggests that successful BT for motor symptoms does not fully resolve associated psychological distress.
• Emphasizes the importance of psychiatric evaluation and integrated treatment approaches, including psychotherapy and psychopharmacotherapy, for managing mental health in BS.